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The transcription factor Klf4 has demonstrated activ-
ity in the reprogramming of somatic cells to a pluripo-
tent state, but the molecular mechanism of this
process remains unknown. It is, therefore, of great
interest to understand the functional role of Klf4 and
related genes in ESC regulation. Here, we show that
homozygous disruption of Klf5 results in the failure
of ESC derivation from ICM cells and early embryonic
lethality due to an implantation defect. Klf5 KO ESCs
show increased expression of several differentiation
marker genes and frequent, spontaneous differentia-
tion. Conversely, overexpression of Klf5 in ESCs
suppressed the expression of differentiation marker
genes and maintained pluripotency in the absence
of LIF. Our results also suggest that Klf5 regulates
ESC proliferation by promoting phosphorylation of
Akt1 via induction of Tcl1. These results, therefore,
provide new insights into the functional and mecha-
nistic role of Klf5 in regulation of pluripotency.
INTRODUCTION
Murine embryonic stem cells (ESCs) are derived from the inner-
cell mass (ICM) of the blastocyst and can be maintained indef-
initely in a self-renewing state (Evans and Kaufman, 1981;CelMartin, 1981). The potential of ESCs to differentiate into specific
cell types may be useful in regenerative medicine. However, ex-
ploitation of ESCs for therapeutic uses requires a better under-
standing of the molecular mechanisms underlying the regulation
of both pluripotency and proliferation of ESCs. Previous studies
revealed that the pluripotency of ESCs is maintained by multiple
soluble factors, such as leukemia inhibitory factor (LIF) (Smith
et al., 1988; Williams et al., 1988), bone morphogenetic protein
(BMP) (Ying et al., 2003), and Wnt (Sato et al., 2004), and nu-
clear transcription factors, such as STAT3 (Niwa et al., 1998;
Matsuda et al., 1999), Oct3/4 (also known as Pou5f1) (Nichols
et al., 1998; Niwa et al., 2000), Nanog (Mitsui et al., 2003; Cham-
bers et al., 2003), Sox2 (Avilion et al., 2003), c-Myc (Cartwright
et al., 2005), and Klf4 (Li et al., 2005). However, the precise mo-
lecular mechanism of self-renewal and how the decision is made
to depart from a self-renewing state remains unclear.
Takahashi and Yamanaka reported that rodent somatic cells
could be reprogrammed into pluripotent ES-like cells by forced
expression of four genes, c-Myc, Oct3/4, Sox2, and Klf4 (Taka-
hashi and Yamanaka, 2006), suggesting that these factors
regulate both the reprogramming of somatic cells and the pluri-
potency of ESCs. Importantly, the same combination of tran-
scription factors was able to reprogram human somatic cells
into pluripotent cells (Takahashi et al., 2007; Park et al., 2007;
Wernig et al., 2007; Yu et al., 2007). The molecular mechanism
of the reprogramming process is still poorly defined, although
recent reports indicate that the gene-expression signature of
the somatic cell changes in a stepwise manner that leads
to the expression of pluripotency-related genes (Brambrinkl Stem Cell 3, 555–567, November 6, 2008 ª2008 Elsevier Inc. 555
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programming, Oct3/4 and Sox2 have an indispensable function
in ESC self-renewal as well as in early embryonic development.
Little is known regarding the contribution of Klf4 to ESC self-
renewal and early embryonic development. Klf4 is a member of
the Kr€uppel-like factor (Klf) family of transcription factors, whose
members are conserved from flies to humans. Proteins of the Klf
family have been shown to act upon different aspects of devel-
opment and physiological function (Ghaleb et al., 2005; Suske
et al., 2005; McConnell et al., 2007). Targeted gene inactivation
ofKlf4 in mice results in perinatal lethality due to defective forma-
tion of the skin’s epithelial barrier and goblet cell differentiation
(Segre et al., 1999; Katz et al., 2002). This may imply that other
members of the Klf family are capable of compensating for the
loss of Klf4 function in the ICM or in ESC maintenance, and/or
Klf4 functionally mimics the activity of a Klf member that plays
a critical role in ICM development and ESC self-renewal. Consis-
tent with this idea, other members of the Klf family, such as Klf1,
Klf2, and Klf5, can substitute for Klf4 function to induce pluripo-
tency (Nakagawa et al., 2008). In a very recent report by Jiang
et al., triple knock-down of Klf4, Klf2, and Klf5 was shown to re-
sult in defective self-renewal of mouse ESCs, while single knock-
downs did not exhibit significant phenotypes (Jiang et al., 2008).
These studies suggest that the Klf family members may have
similar functions in mouse ESC self-renewal, ICM development,
and somatic cell reprogramming.
Here, we show that the Klf5-deficient embryos fail to implant
due to defective trophectoderm development. We also show
that Klf5 is required for the derivation of ESCs from ICM cells. In-
terestingly, Klf5-deficient ESCs can be established by knocking
out both Klf5 alleles in mouse ESCs. The Klf5 knockout (KO)
ESCs can maintain pluripotency but show increased expression
of differentiation-related genes and frequent, spontaneous dif-
ferentiation. Conversely, overexpression of Klf5 in ESCs sup-
presses the expression of differentiation-related genes, resulting
in LIF-independent self-renewal. Klf5 also regulates ESC prolif-
eration by regulating the Tcl1-Akt1 signaling pathway. Taken to-
gether, Klf5 is an indispensable factor for ESC derivation from
ICM cells and is essential for normal self-renewal of mouse
ESCs.
RESULTS
Loss of Klf5 Results in Defective Implantation
and Failure of ESC Derivation from ICM Cells
Bteb2/Klf5 was originally identified as a transcription factor that
recognizes the basic transcription element (BTE), a GC-box se-
quence found within the Cyp1a1 gene promoter (Imataka et al.,
1992; Sogawa et al., 1993). To further explore the function of
Klf5, we generated Klf5 knockout (KO) mice by inserting
a lacZ-neo cassette into the 2nd exon of the gene (Figure S1
available online). Klf5 heterozygous animals were viable and fer-
tile, whereas no homozygous pups were obtained from hetero-
zygous intercrosses, consistent with a previous report (Shindo
et al., 2002). Since no Klf5 KO embryos were observed 6.5
days postcoitus (dpc) with infrequent empty deciduas at the
same time point (Figure 1A), we concluded that Klf5 KO embryos
fail to implant. In agreement with this hypothesis, Klf5 KO em-
bryos at the blastocyst stage were found in the frequencies556 Cell Stem Cell 3, 555–567, November 6, 2008 ª2008 Elsevier Inpredicted by Mendelian inheritance. To gain insight into the
mechanism of the implantation defect, we first examined Klf5
expression. RT-PCR analysis demonstrated Klf5 expression at
the 2-cell stage, and immunohistochemistry using an anti-Klf5
antibody showed Klf5 protein in the ICM and trophoblastic cells
of the blastocyst (Figures 1B and 1C). Abundant Klf5 expression
was also observed in ESCs (Figure 1D). The expression pattern
of Klf5 in the blastocyst was also visualized by b-galactosidase
activity in Klf5-lacZ knockin mice (Figure S2), showing lacZ
expression in the ICM and trophoblastic cells of the blastocysts
(Figure S2). The lacZ expression was seen in the primitive streak
similar to the distribution of Brachyury, a target gene of the Wnt
signaling pathway. This observation concurs with a previous
report showing that Klf5 is a Wnt-inducible gene (Ziemer et al.,
2001).
We also monitored the trophoectodermal expression of Cdx2,
which is required for implantation (Strumpf et al., 2005) (reviewed
in Yamanaka et al., 2006). Significantly, although Cdx2-specific
expression could be detected in the trophoectoderm of wild-
type (WT) blastocysts, as reported previously (Strumpf et al.,
2005), its expression was markedly reduced in Klf5 KO embryos
(Figure 1E). It is not clear whether the lack of Cdx2 expression or
a different mechanism is the major cause of the implantation de-
fect seen in Klf5 KO embryos, as there are some phenotypic dif-
ferences relative to Cdx2 KO embryos. For example, in contrast
to the ectopic expression of Nanog and Oct3/4 in the trophoec-
toderm of the Cdx2 KO mice (Strumpf et al., 2005), Klf5 KO em-
bryos show no such change (Figure 1F; data not shown). This
suggests that there are transcriptional differences between
these two types of KO mice.
To demonstrate that defects in the trophectoderm layer of the
Klf5 KO embryo can prohibit normal implantation, we aggre-
gated WT tetraploid embryos and diploid Klf5 KO ESCs, with
the expected outcome that tetraploid cells would contribute to
the trophectoderm and complement the defect in Klf5 KO cells.
Aggregated embryos implanted successfully (Figure S3E), dem-
onstrating that Klf5 function in the trophectoderm layer is essen-
tial for the implantation process.
To better understand the events surrounding implantation, we
attempted an outgrowth assay (Figure 2A). WT trophectoderm
cells exhibited outgrowth formation and WT ICM-derived cells
formed cell clumps. The majority of Klf5 KO blastocysts (23 of
36, or 64%) failed to attach to the dish (Figures 2A and 2B).
This is again different from Cdx2 KO embryos, which were inca-
pable of attaching to the dish regardless of the type of extracel-
lular matrix substrate used (Strumpf et al., 2005). One-third (13 of
36) of the Klf5 KO blastocysts attached and exhibited outgrowth
but failed to form an aggregate (Figure 2B). In order to directly
investigate the role of Klf5 in ICM development, the ICMwas iso-
lated from blastocysts that were obtained by heterozygous inter-
cross and cultured in ES medium (Figure 2C). After 2 weeks in
culture, ESC lines were identified and genotyped. No Klf5 KO
ESCs were detected (Figure 2D), demonstrating that Klf5 is re-
quired for the transition to the ESC state in a cell-autonomous
manner. The fact that Klf5 KO ESCs could yield 8.5 dpc embryos
with no gross abnormalities in the tetraploid complementation
assay indicates that Klf5 is not required for ICM development
per se once ICM cells develop into ESC-like state. A similar phe-
notype is seen in Mbd3 KO embryos, in which Mbd3/ ESCsc.
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Essential Roles of Klf5 in Stem Cell FunctionFigure 1. Klf5 KO Embryos Show Implantation Defects
(A) Genotype of embryos or pups from an intercross of Klf5 heterozygous mutant littermates at the indicated stages of development.
(B) Klf5 expression begins at the 2-cell stage in WT mice, based on RT-PCR analysis.
(C) Immunohistochemical analysis of Klf5 demonstrating ubiquitous expression in both morula and blastocyst. The upper and lower panels show the morula and
blastocyst stained with anti-Klf5 antibody, respectively.
(D) Northern blot analysis of Klf5mRNA demonstrating expression in both ESCs and trophoblast stem (TS) cells. RNA was recovered from undifferentiated ESCs
and TS cells for the analysis of Klf2, Klf4, Klf5, Cdx2, Nanog, and Gapdh expression.
(E) Analysis of Cdx2 expression in Klf5 KO blastocysts.
(F) Comparison of Nanog expression in Klf5 KO and WT blastocysts. YOYO, staining of nuclei; WT, wild-type embryos; KO, Klf5 KO embryos.can be established fromMbd3 heterozygous ESCs, but not from
Mbd3 KO ICM cells (Kaji et al., 2007).
Klf5 KO ESCs Show Increased Expression
of Differentiation-Related Marker Genes and Undergo
Frequent, Spontaneous Differentiation
Because we were unable to obtain ICM cells from Klf5 KO blas-
tocysts, we examined the effect of loss of Klf5 function in estab-
lished ESC lines (Figure 3A). Klf5 KO ESC lines were established
by replacing the WT allele of Klf5 in heterozygous ESCs with an
IRES-hygr cassette (Figure S3). Although the Klf5 KO ESCs dis-
played markedly reduced proliferation as shown below (Fig-
ure 5), they showed typical ESC morphology during early pas-
sages (Figure 3A). Consistent with their undifferentiated
morphology, Klf5 KO ESCs showed similar levels of Nanog pro-
tein (Figure 3B) andNanog,Oct3/4, Fgf4, and Sox2mRNA toWT
cells (Figure 3B). Teratomas from Oct3/4-positive Klf5 KO ESCs
exhibited successful differentiation into the three germ layers
(Figure 3C), and Klf5 KO ESCs were able to contribute to all
three germ layers when injected into WT blastocysts
(Figure 3D), demonstrating the ability of early pssage Klf5 KO
ESCs to maintain pluripotency. However, as Klf5 KO ESCs
were passaged for longer periods, they revealed a differentiatedCemorphology and exhibited reduced Nanog expression, while WT
ESCs maintained a normal, undifferentiated state (data not
shown), indicating a possible role of Klf5 in ES self-renewal.
To investigate the role of Klf5 in ES self-renewal in more detail,
we established uniform Oct3/4-positive ESC populations by
knocking-in a drug-resistant gene, zeocinr, into the Oct3/4
locus. Only Oct3/4-positive cells would be expected to survive
in the presence of zeocin. RNA was prepared from these cells
and then subjected to qPCR (Figure 3E). Consistent with the
northern blot analysis, we observed no significant differences
in the expression of markers of the undifferentiated state such
as Oct3/4, Rex1, and Nanog between WT, heterozygous, and
KO ESCs, indicating that Klf5 KO ESCs maintain pluripotency
at the molecular level. However, qPCR analysis of differentiation
markers showed that the expression of Fgf5 (a primitive ecto-
derm marker), Brachyury (T, a mesoderm marker, but this is
also expressed in undifferentiated ESCs), and Cdx2 (a trophec-
toderm marker) were increased in Klf5 KO ESCs (Figure 3E). In-
creased expression of Cdx2 has been reported to direct ESCs
toward the trophoblastic lineage (Niwa et al., 2005). Thus, the in-
creased expression of Cdx2, Brachyury, and Fgf5 in Klf5 KO
ESCs suggests that Klf5 KO ESCs might be primed to undergo
differentiation. Consistent with this idea, when Klf5 KO ESCsll Stem Cell 3, 555–567, November 6, 2008 ª2008 Elsevier Inc. 557
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Essential Roles of Klf5 in Stem Cell FunctionFigure 2. Klf5 Is an Indispensable Klf Family Member for the Derivation of ESC from the ICM
(A) Phase contrast images of outgrowth cultures from WT (WT) and Klf5 KO (KO) blastocysts.
(B) Analysis of attachment and outgrowth of WT and KO blastocysts. The number in brackets indicates blastocysts that did not attach to the dish. After the out-
growth assay, the outgrowthswith/without the ICM-derived cell clump and floating blastocysts were recovered. The genotypesswere determined as described in
the Experimental Procedures.
(C) Highly proliferative ICMcells isolated fromwild-type blastocysts. The isolated ICMcells were cultured in ESCmedium for 2weeks on a gelatin-coated dish and
were genotyped.
(D) Summary of immunosurgery experiments. Twenty-two ESC lines were established andwere genotyped. There was noKlf5KOESC line. The N.D. group is that
in which the genotype could not be determined. There were two classes: the isolated ICM cells that attached after immunosurgery but did not grow and the ICM
cells that were floating without any sign of proliferation.were cultured in the absence of zeocin, providing a permissive
environment for differentiation, the ESCs displayed a differenti-
ated morphology (data not shown). To evaluate the efficiency of
spontaneous differentiation, we designed the experiment shown
in Figure S4. ESCs were cultured in the presence of zeocin to
enrich for Oct3/4-positive cells, then transferred to medium
without zeocin, and cultured for 5 days, and alkaline phospha-
tase (AP) activity wasmeasured, which is a marker of undifferen-
tiated ESCs (Figure S4). The ES colonies were classified into five
groups according to the percentage of AP+ cells (Figure S4).
Two independent Klf5 KO ESCs generated colonies displayed
a large degree of differentiation, demonstrating that Klf5 is
important for the suppression of differentiation of ESCs
(Figure S4). Furthermore, when embryoid bodies were prepared
to analyze differentiation in the absence of LIF, increased ex-
pression of Brachyury, Gata4, Fgf5, and Scl (a marker for he-
mangioblasts) was observed 1 day earlier in Klf5 KO ESCs rela-
tive to Klf5WT ESCs (Figure 3F; data not shown). To assess the
differentiation kinetics toward the neural lineage, ESCs were
subjected to a neural sphere assay (Figure 3G). The number of
spheres originating from Klf5 KO ESCs were fewer than that of
WT. Secondary spheres from Klf5 KO ESCs showed abundant
expression of various differentiation markers, such as bIII tubu-
lin, in sharp contrast to that of WT cells, suggesting that Klf5 KO
ESCs can differentiate earlier than WT ESCs. This may reflect
priming of the differentiation process in Klf5 KO ESCs.558 Cell Stem Cell 3, 555–567, November 6, 2008 ª2008 Elsevier InOverexpression of Klf5 Suppresses the Expression
of Differentiation-Related Genes and Supports
Pluripotency in the Absence of LIF
As Klf5 KO ESCs expressed a higher level of differentiation-
related markers, we considered that Klf5 could play a role in
maintaining the pluripotent state of ESCs by suppressing the ex-
pression of differentiation-related genes. Thus, we investigated
whether overexpression of Klf5 in ESCs suppresses the expres-
sion of differentiationmarkers (Figure 4). We establishedmultiple
ESC lines expressing different levels of a FLAG/HA-tagged Klf5
protein. (Figure 4B). qPCR analysis indicated that the expression
of differentiation-related genes, such as Fgf5 and Brachyury, is
suppressed in ESCs overexpressing Klf5 compared to their ex-
pression in WT ESCs (Figure 4C). We speculated that ESC lines
overexpressing Klf5 might be resistant to differentiation signals
and, therefore, examined the effect of culturing the cells in the
absence of LIF for 5 days. Over 99% of the colonies derived
from WT ESCs showed differentiated cell morphology and lost
AP activity (Figure 4D). By contrast, 81% of the colonies derived
from ESCs (overexpressor line no. 6) that expressed a level of
FLAG/HA epitope-tagged Klf5 equivalent to endogenous Klf5
exhibited an undifferentiated morphology and strong AP activity,
indicating that they hadmaintained a pluripotent state even in the
absence of LIF (Figure 4C). Robust maintenance of pluripotency
was confirmed by the prolonged culture of ESCs carrying a re-
movable Klf5 transgene in the absence of LIF. Subsequentc.
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cysts showed that these ESCs had retained the ability to gener-
ate chimeric embryos (H.N. and D.S., unpublished data).
Klf5 Regulates ESC Proliferation through
the Tcl1-Akt1 Pathway
During the course of the current study, a very interesting obser-
vation was the critical role that Klf5 plays in ESC proliferation.
Klf5 KO ESCs proliferated more slowly than WT, whereas the
ESC lines overexpressing Klf5 proliferated more quickly than
WT (Figure 5A; Figures S5A–S5C). Teratomas derived from
Klf5 KO ESCs also showed a similar cell proliferation defect (Fig-
ures S5D and S5E). A comparison of the cell-cycle distribution of
Klf5 KO and WT ESCs revealed a larger G1 peak population in
the KO cells (Figures 5B and 5C), indicating that the G1 period
is longer in Klf5 KO ESCs than in WT cells. Conversely, the G1
period was shorter in Klf5-overexpressing cell lines relative to
WT cells (Figures 5B and 5C). Multiple regulators, such as cyclins
and cyclin-dependent kinase inhibitors, control the G1 check-
point. It has been reported that p21cip1, but not p16ink4a or
p19arf, can inhibit ESC proliferation (Savatier et al., 1996). Inter-
estingly, the expression of p21cip1 is increased in Klf5 KO ESCs
(Figure 5D). Because the p21cip1 promoter has multiple GC
boxes and is regulated by GC box-binding proteins (Gartel
et al., 2001) and Klf factors (Zhang et al., 2000; Ghaleb et al.,
2005), we investigated whether Klf5 regulates p21cip1 promoter
activity in ESCs. Transient transfection assays indicated that ex-
ogenous Klf5 expression repressed p21cip1 reporter activity in
wild-type ESCs in a dose-dependent manner (Figure 5E). Con-
sistent with the upregulation of the p21cip1 gene in Klf5 KO
ESCs, p21cip1 reporter activity was induced in Klf5 KO ESCs
(Figure 5E). As Klf5 behaves as a transcriptional activator in
most cells, we did not expect that it would act as a transcriptional
repressor. So, we examined whether Klf5 binds to the transcrip-
tional repressor complex comprising the histone-deacetylase
complex (HDAC) 1/2 andMTA2, a component of the nucleosome
remodeling and histone deacetylation (NuRD) complex
(Figure 5F). Nuclear cell extracts were prepared from Klf5 KO
ESCs expressing FLAG-HA-tagged Klf5 protein. After immuno-
precipitation with an anti-FLAG antibody, we conducted western
blot analysis with antibodies against HDAC1, HDAC2, and
MTA2. The analysis clearly indicated that Klf5 bound HDAC2
and MTA2, but not HDAC1, suggesting that it acts as transcrip-
tional repressor through the binding of HDAC2 and MTA2
(Figure 5F). To investigate whether induction of p21 cip1 could
account for the reduction in ESC proliferation, we knocked
down the p21cip1 mRNA by siRNA and found that p21cip1
knockdown does not rescue the defect in ESC proliferation (Fig-
ures S5F and S5G). Furthermore, the defect in ESC proliferation
was not rescued by triple knockdown of p21cip1, p16ink4a, and
p19 arf (Figures S5H and S5I). Taken together, our observations
suggest that Klf5 can regulate ESC proliferation, perhaps partly
as a consequence of p21cip1 suppression, but with the addi-
tional involvement of other unknown genes. To identify additional
downstream genes, we surveyed genes implicated in ESC pro-
liferation by microarray analysis and found that the Akt coactiva-
tor Tcl1 is significantly downregulated in Klf5 KO ESCs (Table
S1). This result was confirmed by qPCR analysis (Figure 6A). Im-
portantly, when Tcl1 mRNA was knocked down in WT cells, G1Ceprogression was prolonged (Figure S6), consistent with the
idea that the regulation of G1 progression by Klf5 is mediated
in part by Tcl1. Previous reports showed that Tcl1 regulates
ESC proliferation (Ivanova et al., 2006; Matoba et al., 2006) by
activating the phosphorylation state of Akt1. The phosphoryla-
tion of Akt1 is clearly downregulated in Klf5 KO ESCs
(Figure 6B). To investigate whether Akt1 is a functional down-
stream target for Klf5, we introduced a vector that expressed
constitutively active Akt1 into Klf5 KO ESCs and found that
Akt1 could partially, but significantly, rescue the proliferation de-
fect of Klf5 KO ESCs (Figure 6C).
Our results suggest that Klf5 plays a critical role on ESC
expansion by controlling both G1 progression (Figure 5B) and
the colony-forming ability (cell adhesion and/or survival)
(Figure S5C), thus leading to a notable improvement in cell pro-
liferation. Therefore, manipulation of Klf5 function may allow us
to improve the expansion efficiency of stem cells such as hESC.
Recent reports indicate that Klf family molecules have overlap-
ping functions (Basu et al., 2007). For example, it has been
reported that Klf4 overexpression prevents differentiation of
ESCs (Li et al., 2005), indicating that Klf4 and Klf5may have sim-
ilar biological functions in ESCs. Furthermore, at a molecular
level, Klf4 can repress p21cip1 reporter expression in a similar
dose-dependent manner as Klf5 (Figure S7). PreviousKlf4 siRNA
knockdown experiments indicate that Klf4 may regulate the ex-
pression of 28 genes, including Tcl1, Ly75, 1200015N20Rik, and
Notch4 in cooperation with Oct3/4 (Nakatake et al., 2006). Inter-
estingly, Tcl1, Ly75, 1200015N20Rik, andNotch4 are downregu-
lated in Klf5 KO ESCs (Table S1; data not shown). Thus, Klf4 and
Klf5 may regulate a similar subset of target genes in ESCs, al-
though it has been reported that they exhibit opposite transcrip-
tional control on a subset of genes (McConnell et al., 2007). Since
Klf4 mRNA is still abundant in Klf5 KO ESCs (Figure S7B), Klf4
expression may partially compensate for the Klf5 KO phenotype.
Consistent with this idea, very recently, Jiang and coworkers re-
ported that Klf2, Klf4, and Klf5 cooperate in the self-renewal of
mouse ESCs (Jiang et al., 2008). In parallel to their study, we per-
formed Klf2 and Klf4 knockdown experiments in the Klf5 KO
ESCs (Figure S8). Importantly, Nanog expression was downre-
gulated in Klf2/4 knockdown/Klf5 KO ESCs, whereas Oct3/4
expression was maintained. Tcl1 expression was further de-
creased in Klf2- and Klf4-downregulated ESCs in a Klf5 KO
background. On the other hand, the expression of Fgf5 and Bra-
chyury were further elevated. Thus, Klf factors display coopera-
tive activity with respect to regulation of ESC self-renewal.
One question that has not been rigorously addressed is
whether Klf factors function in a totally redundant manner or if in-
dividual Klf family members have unique, nonoverlapping func-
tions. In order to investigate this, we examined whether Klf4
could rescue the defects observed in Klf5 KO ESCs (Figure 7).
Two independent Klf4-overexpressing Klf5 KO ESC lines were
established, and the expression levels of differentiation-related
markers were evaluated. Fgf5 and Brachyury expression was
clearly suppressed to levels below that of Klf5 KO ESCs
(Figure 7B). In addition, these Klf4 overexpressing Klf5 KO
ESCs could be maintained in an undifferentiated state even in
the absence of LIF (Figure 7C). These data suggest that Klf4
has a similar function to Klf5 in the suppression of differentiation.
On the other hand, the Klf4-overexpressing Klf5 KO ESCsll Stem Cell 3, 555–567, November 6, 2008 ª2008 Elsevier Inc. 559
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Essential Roles of Klf5 in Stem Cell FunctionFigure 3. Klf5 KO ESCs Express Higher Levels of Differentiation-Related Genes and Undergo Spontaneous Differentiation
(A) Nanog expression in WT and Klf5 KO ESCs. Scale bar indicates 50 mm. Hoechst 33342 was used to stain cell nuclei.
(B) Expression of pluripotency markers in WT and Klf5 KO ESCs. +/, heterozygotes.
(C) Various tissues types are present in teratomas derived from Klf5 KO ESCs, including bone marrow (mesoderm-derived, upper left), chondrocyte (mesoderm-
derived, upper middle), ciliated epithelium (endoderm, upper right), muscle (mesoderm-derived, lower left), neuroepithelium (ectoderm-derived, lower middle),
and keratinized stratified squamous epithelium (ectoderm-derived, lower right).
(D) Analysis of the differentiative potential of Klf5 KO ESCs by blastocyst injection. Control WT embryo and an embryo injected with GFP-labeled Klf5 ESCs are
shown on the left- and right-hand side, respectively.
(E) qPCR analysis comparing the expression of mRNAs encoding early lineage markers in Klf5 +/+:: Oct3/4-zeocinr ESCs (WT1), Klf5 +/:: Oct3/4-zeocinr ESCs
(+/), and Klf5 KO:: Oct3/4-zeocinr ESCs (KO1 and -2).
(F) Time-course ofKlf5, Fgf5, andBrachyury expression relative to the expression of b-actin in embryoid bodies derived fromWT, heterozygote (+/), and Klf5KO
ES (KO1 and -2) in the absence of LIF.560 Cell Stem Cell 3, 555–567, November 6, 2008 ª2008 Elsevier Inc.
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fers from what was observed with Klf5. Taken together, Klf4
and Klf5 appear to have a similar function in the suppression of
differentiation, but their roles with respect to cell proliferation
may be different.
DISCUSSION
Klf5 Is an Indispensable Klf Family Member
for the Derivation of ESCs from the ICM
and for the Implantation Process
The Klf protein family consists of 17 members that have funda-
mental roles in various physiological and developmental pro-
cesses (Suske et al., 2005; McConnell et al., 2007). For in-
stance, Klf2 and Klf4 regulate hematovascular development
and skin barrier formation, respectively (Lee et al., 2006; Segre
et al., 1999). To date, there have been no reports that a Klf fac-
tor can regulate early embryonic progression such as during
ICM development. As Jiang et al. suggested that Klf2 and
Klf4 can cooperate in the self-renewal of ESCs together with
Klf5 (Jiang et al., 2008), it is possible that Klf2, Klf4, and Klf5
also may cooperate in ICM development at the blastocyst
stage. Our studies, however, clearly demonstrate that Klf5 is
a crucial factor for the derivation of ESCs and/or ICM develop-
ment, in contrast to the dispensable role of Klf2 or Klf4 in these
processes.
(G) Marker expression for neuron, glia, and oligodendrocyte in the neural spheres derived from ESCs. Left panel shows primary spheres derived from ESCs. Mid-
dle panel shows the results of sphere assays. Right panel shows increased number of neurons (bIII tubulin-positive), glias (GFAP-positive), and oligodendrocytes
(O4-positive) observed in Klf5 KO ES-derived secondary spheres. Bar indicates 100 mm. Graphed results are the means and SEM of three independent exper-
iments. *p < 0.05.
Figure 4. LIF-Independent Self-Renewal in ESCs Overexpressing Klf5
(A) The establishment of ESC lines overexpressing Klf5. Western blot analysis of cell lysates prepared from multiple ESC lines using anti-Klf5 and b-actin anti-
bodies. The panel shows ESC lines that overexpress FLAG/HA-tagged Klf5. WT ES (lane 1), WT:: Oct3/4 -zeocinr ES that overexpress FLAG/HA-tagged Klf5
(lanes 2–7) and KO ES (lane 8).
(B) Quantification of Klf5 protein levels in multiple ESC lines described in (A). Endogenous Klf5 protein levels were calculated from the signal intensities of the
endogenous bands normalized to b-actin protein levels. Exogenous FLAG/HA-tagged Klf5 protein levels were calculated as a percentage of endogenous Klf5
protein. Endogenous and exogenous Klf5 protein levels are shown in closed and open boxes, respectively.
(C) Suppression of differentiation-related genes in Klf5 overexpressing ESCs. Klf5 is able to suppress Fgf5, Brachyury, Gata4, and Cdx2 in a dosage-dependent
manner.
(D) Summary of LIF-independent assay. WT:: Oct3/4 -zeocinr ES (lanes 1and 2) and five independent WT:: Oct3/4 -zeocinr ES which overexpress FLAG/HA
tagged Klf5 (lanes 3–12) were cultured in the presence (odd-numbered lanes) or absence (even-numbered lanes) of LIF for 5 days and were subjected to alkaline
phosphatase assay. Type A and Type B, described in Figure S4, were used as standards for undifferentiated colonies. Graphed results are the mean and SEM of
three independent experiments. *p < 0.05.Cell Stem Cell 3, 555–567, November 6, 2008 ª2008 Elsevier Inc. 561
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(A) Growth rate of Klf5WT, KO, and overexpressing ESCs. Two independent Klf5 KO:: Oct3/4 -zeocinr ES lines (KO1 and KO2) described in Figure 3E and four
independent Klf5 overexpressor lines (over 4–7) described in Figure 4A were used in this study.
(B) Cell-cycle analysis of Klf:: Oct3/4 -zeocinr WT, KO:: Oct3/4 -zeocinr, and Klf5 overexpressor:: Oct3/4 -zeocinr ESCs. ESCs were preselected for Oct3/4 ex-
pression in the presence of zeocin and were subjected to cell-cycle analysis. The G1 phase is longer inKlf5 KO ESCs than inWT, whereas the G1 phase is shorter
in Klf5 overexpressing ESCs than in WT. Two independent ESC lines were used for the analysis, and consistent data were obtained.
(C) Statistical analyses of cell-cycle status.
(D) Quantitative PCR analysis of the expression of p21 cip1, p16 ink4a, and p19 arf inKlf5 +/+::Oct3/4 -zeocinr ESCs (WT1),Klf5 +/::Oct3/4 -zeocinr ESCs (+/),
and Klf5 KO:: Oct3/4 -zeocinr ESCs (KO1 and -2).
(E) Klf5 represses transcription of the p21 cip1 promoter. Human p21 cip1 promoter reporter plasmid was transfected into WT or Klf5 KO ESCs together with
different doses of the Klf5 expression plasmid.
(F) Klf5 forms a complex with HDAC2 and MTA2. Nuclear extracts were prepared from Klf5 KO ESCs overexpressing either nontagged (odd-numbered lanes) or
FLAG/HA-tagged (even-numbered lanes) Klf5. After immunoprecipitation with an anti-FLAG antibody (lanes 3 and 4), western blot analysis was performed to
investigate complex formation with HDAC1/2 and MTA2. As a positive control, whole-cell extract was used to detect endogenous expression of HA-tagged pro-
tein, HDAC1/2, and MTA2 (lanes 1 and 2). Graphed results are the means and SEM of three independent experiments. *p < 0.05.Triple knock-down of Klf2, Klf4, and Klf5 in ESCs resulted
in increased expression of Fgf5 and Brachyury and decreased
expression of Nanog and Tcl1 (Jiang et al., 2008). This gene
expression signature is similar to that of EpiSC, which is a plu-
ripotent cell line derived from the epiblast (Brons et al., 2007;
Tesar et al., 2007). Interestingly, Klf5 KO ESCs also show an
increased expression of Fgf5 and Brachyury and a decreased
expression of Tcl1, although the alteration was to a lesser
extent than in the triple knockdown, and Nanog expression562 Cell Stem Cell 3, 555–567, November 6, 2008 ª2008 Elsevier Iremained unchanged. Furthermore, Klf5 KO ESCs can differ-
entiate earlier than WT ESCs, suggesting that Klf5 KO ESCs
may be primed for differentiation toward EpiSC cells. Consis-
tent with this idea, Klf5 is expressed abundantly in ICM
cells at the blastocyst stage but is not detectable in the epi-
blast of embryos at 5.5 and 6.5 dpc (Figure 1 and Figure S2),
implying that the downregulation of Klf5 expression may be
required for the differentiation of the ICM cells into epiblast
cells.nc.
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Essential Roles of Klf5 in Stem Cell FunctionFigure 6. Tcl1-Akt1 Pathway Acts Downstream of Klf5 in ESC Proliferation
(A) qPCR analysis for the expression of Tcl1 inKlf5WT::Oct3/4 -zeocinr ESCs (WT1),Klf5KO::Oct3/4 -zeocinr ESCs (KO1 and -2), andWT::Oct3/4 -zeocinr ESCs
that overexpress FLAG/HA-tagged Klf5 (over 6).
(B) Reduction in the level of phosphorylated Akt1 in Klf5 KO:: Oct3/4 -zeocinr ESCs.
(C) The myristated form of Akt1 rescues the reduced proliferative capacity of Klf5 KO::Oct3/4 -zeocinr ESCs. hAkt1 (WT), and a constitutively active Akt1 expres-
sion plasmid (CA) were introduced into Klf5 KO:: Oct3/4 -zeocinr or WT:: Oct3/4 -zeocinr ESCs along with GFP expression plasmid. After 1 day, GFP-positive
ESCs were sorted by FACS, and the same number of ESCs were plated and counted after 3 days.
(D) Schematic model of how Klf5 regulates self-renewal of ESCs. Klf5 represses the expression of p21cip1 and activates Akt1 phosphorylation through Tcl1 ex-
pression resulting in a shortened G1 phase, thereby contributing to proliferation. Klf5 also represses differentiation-related genes, such asBrachyury,Cdx2, Fgf5,
and others, and activatesNanog. p21cip1 prevents ESC proliferation according to Savatier et al. (1996). Thus, Klf5 plays a role in the self-renewal of mouse ESCs.
Graphed results are the means and SEM of three independent experiments. *p < 0.05.Klf5-deficient blastocysts fail to implant. The exact molecular
mechanism of implantation defect is not clear.Cdx2, which is re-
quired for the implantation process, is downregulated in Klf5 KO
embryos (Figure 1E), but it is not clear whether the lack of Cdx2
expression or a differentmechanism is themajor cause of the im-
plantation defect of the Klf5 KO embryos, as there are pheno-
typic differences between Klf5 and Cdx2 KO embryos. More-
over, in contrast to the downregulation of Cdx2 in Klf5 KO
blastocysts, Cdx2 expression is in fact upregulated in Klf5 KO
ESCs, revealing a differential effect of Klf5 loss on Cdx2 expres-
sion. It is not clear what the mechanistic basis of this differential
effect is. However, one clue might come from the observation
that Klf5 binds to PPAR-d and, in the absence of ligand Klf5, is
modified by SUMO and binds to a corepressor to repress a set
of genes (Oishi et al., 2008). Upon ligand binding, Klf5 is de-
SUMOlylated and binds to CBP and p300 (coactivator) and acti-
vates the same set of genes. Thus, in another context, Klf5 is able
to repress and activate the same genes in a ligand-dependent
manner. In addition, Sauer and Jackle showed that Kr€uppel in
the fly regulates gene expression in a concentration (Kr€uppel
protein)-dependent manner (Sauer and Ja¨ckle, 1991), suggest-
ing another potential mechanism for a differential effect. It is
also possible that in either the embryo or the ESCs, the observed
effect on Cdx2 is indirect and not in fact a result of differential
regulation by Klf5.
Role of Klf5 for ESC Self-Renewal
Rodent and human somatic cells can be reprogrammed into iPS
cells with four transcription factors (Takahashi and Yamanaka,
2006; Takahashi et al., 2007; Maherali et al., 2007; Okita et al.,
2007; Park et al., 2007; Wernig et al., 2007). As iPS cells are
very similar to ESCs in terms of their gene expression profile,CeDNA methylation, and chromatin status (Yu et al., 2007), they
may prove a valuable resource for autologous transplantation in-
stead of ESCs (Hanna et al., 2007). The mechanism through
which the reprogramming process is achieved is largely un-
known and involves sequential induction of pluripotency marker
genes after forced expression of the four transcription factors
(Brambrink et al., 2008; Stadtfeld et al., 2008). In comparison
to the genes Oct3/4 and Sox2, whose role in pluripotency was
well established, Klf4 was an unexpected component, because
target inactivation of Klf4 in the mouse results in postnatal lethal-
ity and defects in skin barrier formation and goblet cell differen-
tiation (Segre et al., 1999; Katz et al., 2002). This may imply that
other Klf factors can functionally compensate for the insuffi-
ciencies of Klf4 KO embryos. Consistent with this idea, Naka-
gawa et al., demonstrated that other members of the Klf family,
such as Klf1, Klf2, and Klf5 can substitute for Klf4 function to in-
duce pluripotency (Nakagawa et al., 2008). As Klf5 is required for
ICM development and the derivation of ESCs, understanding the
molecular mechanism of how Klf5 regulates ICM development
and normal ESC self-renewal may allow us to understand how
Klf family members contribute to reprogramming of somatic cells
into iPS cells.
Jiang et al. reported that knockdown of Klf5 did not result in
any significant self-renewal defects in ESCs (Jiang et al.,
2008). This does not seem consistent with our results showing
that Klf5 KO ESCs exhibit increased expression of differentia-
tion-related genes and can undergo frequent, spontaneous dif-
ferentiation under normal ES culture conditions. Klf5 KO ESCs
also show a marked reduction in cell proliferation. When we
used a Klf5 siRNA-expressing vector to knock down endoge-
nous Klf5 expression to 10%–20% normal levels, the ESCs
did not show a cell proliferation defect or spontaneousll Stem Cell 3, 555–567, November 6, 2008 ª2008 Elsevier Inc. 563
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(A) The establishment of Klf4-overexpressing Klf5 KO::Oct3/4 -zeocinr ESCs. FLAG-HA epitope-tagged Klf4 was introduced into Klf5 KO::Oct3/4 -zeocinr ESCs.
(B) Suppression of differentiation-related genes in Klf4 overexpressing Klf5 KO:: Oct3/4 -zeocinr ESCs. Klf4 can suppress Fgf5 and Brachyury.
(C) Summary of LIF-independent assay. WT:: Oct3/4 -zeocinr ES, Klf5 KO ES:: Oct3/4 -zeocinr ESCs, and two independent Klf5 KO:: Oct3/4 -zeocinr ESC lines
which overexpress FLAG/HA-tagged Klf4were preselected for Oct3/4 expression in the presence of zeocin. Then, they were cultured in the presence or absence
of LIF for 5 days and were subjected to alkaline phosphatase assay. Type A and Type B, described in Figure S4, were used as a standard for undifferentiated
colonies. Note that Klf4-overexpressing Klf5 KO ESCs maintain alkaline phosphatase activity even in the absence of LIF.
(D) Representative data of LIF-independent assay described in (C).
(E) Growth rate of WT::Oct3/4 -zeocinr ES, Klf5 KO::Oct3/4 -zeocinr ES, and Klf4-overexpressing Klf5 KO::Oct3/4 -zeocinr ESCs. Graphed results are the means
and SEM of three independent experiments. *p < 0.05.
(F) Overlapping and nonoverlapping functions of Klf4 and Klf5Klf4 and Klf5 function similarly in the suppression of differentiation but have opposing activities on
cellular proliferation.differentiation (data not shown), suggesting that complete elim-
ination of Klf5 expression is important for the phenotype.
Overlapping and Nonoverlapping Functions of Klf4
and Klf5
Recent reports indicate that Klf family members have overlap-
ping functions (Basu et al., 2007). For example, it is reported
that triple knockdown of Klf2, Klf4, and Klf5 resulted in defective
self-renewal of mouse ESCs (Jiang et al., 2008). Consistent with
this, our results indicate that Klf4 has a similar function to Klf5 in
the suppression of differentiation. On the other hand, Klf4-over-
expressing Klf5 KO ESCs showed a reduction in cell prolifera-
tion, a result that is in sharp contrast to Klf5. This observation
is consistent with previous reports showing that Klf4 and Klf5 ex-
ert opposing effects on cell proliferation (Ghaleb et al., 2005).
Taken together, it seems that Klf4 and Klf5 function similarly in
the suppression of differentiation but have opposing activities
on cellular proliferation.
Possible Mechanism of Klf5 for ESC Self-Renewal
Wedemonstrated thatKlf5KOESCs show increased expression
of differentiation-related marker genes, such as Fgf5 and Bra-564 Cell Stem Cell 3, 555–567, November 6, 2008 ª2008 Elsevier Inchyury, while Klf5 overexpression suppresses these marker
genes. Our data also suggest that Klf5 regulates ES proliferation
by controlling Tcl1-Akt1 signaling, suggesting that Klf5 regulates
these fundamental genes directly. Consistent with this idea,
a very recent study by Jiang et al. showed that Klf5 can bind to
a genomic region nearby the Fgf5, Tcl1, and Nanog genes,
based on ChIP-on-ChIP studies (Jiang et al., 2008). Thus, our
studies, in combination with those of Jiang et al., imply that
Klf5 regulates these downstream genes directly. It is of note
that loss of Klf5 alters the expression level of Fgf5 and Tcl1,
but not Nanog, whereas synergistic knockdown of Klf2 and
Klf4 in Klf5 KO ESCs abrogates Nanog expression, indicating
that the dependency on Klf factors is gene-specific.
Wang and coworkers explored the protein-protein network of
factors involved in the control of pluripotency (Wang et al.,
2006). Kim et al. examined the target promoters of Oct3/4,
Sox2, Klf4, c-Myc, and five other transcription factors by
ChIP-on-ChIP analysis and found that significant numbers of
promoters are occupied by these transcription factors (Kim
et al., 2008). It will be interesting to investigate the relationship
of Klf5 to these transcription factors and the target promoters
for Klf5 to understand the molecular mechanism of the processc.
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development.
Possible Relationship between Proliferation
and Differentiation
Forced G1-to-S progression by activated Akt1 kinase has been
reported to induce LIF-independent self-renewal of ESCs, sug-
gesting a possible link between cell-cycle progression (prolifera-
tion) and the maintenance of pluripotency (differentiation) (Wata-
nabe et al., 2006). Indeed, it is well known that cell proliferation
and differentiation do not occur simultaneously. In this regard,
it is of note that only the Klf5-overexpressing ESC lines, which
showed increased cell proliferation, acquired LIF-independent
self-renewal ability, suggesting that enhanced cell-cycle pro-
gression, especially in G1 phase, may reduce the probability of
exit from a self-renewing state. Understanding the molecular
mechanism of how Klf5 regulates both proliferation and pluripo-
tency may shed light on the relationship between cell prolifera-
tion and pluripotency.
Taken together, our results demonstrate that Klf5 function is
required for ESC derivation from ICM cells and normal self-re-
newal of ESCs (Figure 6D). Future studies should determine
the molecular mechanism of how Klf5 regulates blastocyst de-
velopment and represses the expression of differentiation-
inducing genes and enhances the progression of the cell-cycle
in ESCs. Such studies should increase our understanding of
how ESCs maintain their pluripotent and proliferative state, as
well as the reprogramming process of a somatic cell into a plurip-
otent ESC-like state.
EXPERIMENTAL PROCEDURES
Targeting Vectors and Generation of Klf5 KO Mice
The targeting vector for Klf5was constructed by inserting a lacZ-Neo cassette
into the 2nd exon of the Klf5 gene isolated from a 129SV mouse genomic DNA
library. Klf5 KOmice were generated as described in the Supplemental Exper-
imental Procedures. All experiments were performed in accordance with the
Declaration of Helsinki and were approved by University of Tsukuba Ethics
Committee for Animal Experiments.
Real-Time PCR Analysis
For the RT-PCR analysis, first-strand cDNA was synthesized from 1 mg of total
RNA that had been treated with DNaseI in a 20 ml reaction mixture using the
Superscript III first strand synthesis Kit (Invitrogen). The real-time PCR reaction
was performed with a platinum SYBR Green Super Mix UDG (Invitrogen) using
Rox and analyzed on an ABI Prism 7700 system (Applied Biosystems). The
amount of target RNA was estimated using an appropriate standard curve
and divided by the estimated amount of b-actin for normalization. The se-
quences of primers for quantitative PCR are listed in Table S1.
Embryo Manipulation and Cultures
Embryo manipulations were performed according to the procedure described
by Nagy et al. (2003) For blastocyst outgrowth assays, blastocysts were col-
lected at 3.5 dpc from the uterus and exposed to acidified Tyrode’s solution
(Sigma). Immediately after the zona had dissolved, the blastocysts were trans-
ferred into M16 medium (Sigma) and cultured in ES medium for 5 days on a
4-well dish (Nunc). For immunosurgery, blastocysts were incubated with rabbit
anti-mouse red blood cells (Inter-Cell Technologies, Inc., 1:20 in 1 ml) for 10 s.
After a brief wash in M16 + 10% heat-inactivated FBS twice, the blastocysts
were incubated with guinea pig serum (Calbiochem, 1:3) for 30 s. After zona
removal with acidic tyrode, they were cultured in ESC medium for 2 weeks
on a gelatin-coated dish. For the genotyping and confocal imaging of early
mouse embryos, see the Supplemental Experimental Procedures.CeTeratoma Formation
After nude mice were anesthetized with diethyl ether, we injected 1 3 106
ESCs subcutaneously into the dorsal flank. Four weeks after the injection,
tumors were surgically dissected from the mice. Samples were weighed, fixed
in 4% paraformaldehyde, and embedded in paraffin. Sections were stained
with hematoxylin and eosin.
Blastocyst Injection
In order to demonstrate pluripotency, Klf5 KO ESCs were infected with a
GFP-expressing retrovirus (a kind gift from Dr. Masafumi Onodera) to label
the cells and were then injected into blastocysts and transferred into surrogate
C57BL/6 mice. Midgestation embryos were recovered and subjected to tissue
sectioning.
Flow Cytometric Analysis and Cell Proliferation Assay
A BrdU Flow kit (BD Biosciences) was used for cell-cycle analysis after the in-
corporation of BrdU for 2 hr. LSR (BD Biosciences) was used for flow cytomet-
ric analyses. For the Tcl1 siRNA knockdown experiment, the siRNA (Tcl1
Stealth Select 3 RNAi [MSS247834; MSS247832; MSS247833], Invitrogen)
was introduced together with a GFP expression plasmid. After 24 hr, the cells
were incubated in the presence of BrdU and subjected to cell-cycle analysis.
GFP-positive cells were gated for the analysis.
For cell proliferation assay, the siRNAs (p21cip1 and p16ink4a/p19arf) were
introduced together with a GFP or AzamiGreen expression plasmid. After
24 hr, GFP- or AzamiGreen-positive cells were sorted and 2 3 104 cells
were plated and were cultured.
In Vitro Differentiation of ESCs
EBs were generated as described previously (Ema et al., 2003) (see the Sup-
plemental Experimental Procedures). For the immunocytochemistry of neuro-
sphere cells, we used anti-bIII tubulin mouse monoclonal (IgG) (1:400; Sigma),
anti-GFAP rabbit polyclonal (IgG) (1:400; Chemicon), and anti-O4 antigen
mouse monoclonal (IgM) (1:40; Roche) antibodies as primary, followed by
the appropriate Alexa-conjugated secondary antibodies. Cultures were coun-
terlabeled with the nuclear stain Hoechst 33258 (1 mg/ml; Sigma).
Western Blot and Immunoprecipitation Analysis
ESCs were lysed, and western blot was performed as described in the Supple-
mental Experimental Procedures. The membrane was immunoblotted with
mouse anti-mouse Klf5 antibody (YAMASA), rabbit anti-Akt1 antibody (Cell
Signaling Technology), rabbit anti-pSer473Akt1 antibody (Cell Signaling Tech-
nology), or anti-b-actin antibody (Sigma), followed by secondary antibody,
horseradish peroxidase-conjugated anti-mouse IgG (Dako). Immunoreactive
proteins were detected using the enhanced chemiluminescence (ECL) or
ECL plus western blot detection system (Amersham).
To identify the Klf5 protein complex, immunoprecipitation was performed
using cell extracts from Klf5 KO ESCs rescued by expressing untagged or
FLAG/HA-tagged Klf5 (See the Supplemental Experimental Procedures for de-
tails).
Microarray Procedure and Data Analysis
Total RNA was extracted from WT and Klf5 KO ESCs, and the quality of RNA
was determined with an Agilent bioanalyser (Agilent Technologies). The micro-
array procedure was performed as described in Supplemental Experimental
Procedures. The data have been deposited in the Gene Expression Omnibus
database under the accession number GSE9244.
Statistical Analysis
Statistical analyses were performed using the Mann-Whitney U test. Data are
expressed as means and standard error. Differences were considered signif-
icant at p < 0.05.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, eight
figures, and three tables and can be found with this article online at http://
www.cellstemcell.com/supplemental/S1934-5909(08)00456-6.ll Stem Cell 3, 555–567, November 6, 2008 ª2008 Elsevier Inc. 565
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